U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C25H31F3N4O2
Molecular Weight 476.5344
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of EMD-534085

SMILES

CN(C)CCNC(=O)NC[C@H]1CC[C@H]2[C@@H](NC3=C(C=C(C=C3)C(F)(F)F)[C@H]2O1)C4=CC=CC=C4

InChI

InChIKey=MARIUIDCPUZLKZ-FUKQBSRTSA-N
InChI=1S/C25H31F3N4O2/c1-32(2)13-12-29-24(33)30-15-18-9-10-19-22(16-6-4-3-5-7-16)31-21-11-8-17(25(26,27)28)14-20(21)23(19)34-18/h3-8,11,14,18-19,22-23,31H,9-10,12-13,15H2,1-2H3,(H2,29,30,33)/t18-,19+,22+,23+/m1/s1

HIDE SMILES / InChI

Molecular Formula C25H31F3N4O2
Molecular Weight 476.5344
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
8.0 nM [IC50]
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
92.8 ng/mL
2 mg/m² single, intravenous
dose: 2 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
144.4 ng/mL
4 mg/m² single, intravenous
dose: 4 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
202.6 ng/mL
6 mg/m² single, intravenous
dose: 6 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
325.2 ng/mL
9 mg/m² single, intravenous
dose: 9 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
357.8 ng/mL
14 mg/m² single, intravenous
dose: 14 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
680.4 ng/mL
21 mg/m² single, intravenous
dose: 21 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
827.4 ng/mL
32 mg/m² single, intravenous
dose: 32 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
1817 ng/mL
48 mg/m² single, intravenous
dose: 48 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
1563.6 ng/mL
72 mg/m² single, intravenous
dose: 72 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
4757.5 ng/mL
108 mg/m² single, intravenous
dose: 108 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
4275.4 ng/mL
135 mg/m² single, intravenous
dose: 135 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
101.6 ng/mL
2 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 2 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
252.4 ng/mL
4 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 4 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
260.8 ng/mL
6 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 6 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
352.3 ng/mL
9 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 9 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
431 ng/mL
14 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 14 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
430 ng/mL
21 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 21 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
637.1 ng/mL
32 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 32 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
1853.9 ng/mL
48 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 48 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
2759.6 ng/mL
72 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 72 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
4895.8 ng/mL
108 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 108 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
5897.9 ng/mL
135 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 135 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
1345 ng × h/mL
2 mg/m² single, intravenous
dose: 2 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
2804 ng × h/mL
4 mg/m² single, intravenous
dose: 4 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
3134 ng × h/mL
6 mg/m² single, intravenous
dose: 6 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
4495 ng × h/mL
9 mg/m² single, intravenous
dose: 9 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
6379 ng × h/mL
14 mg/m² single, intravenous
dose: 14 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
8883 ng × h/mL
21 mg/m² single, intravenous
dose: 21 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
11288 ng × h/mL
32 mg/m² single, intravenous
dose: 32 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
27695 ng × h/mL
48 mg/m² single, intravenous
dose: 48 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
17659 ng × h/mL
72 mg/m² single, intravenous
dose: 72 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
80526 ng × h/mL
108 mg/m² single, intravenous
dose: 108 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
85223 ng × h/mL
135 mg/m² single, intravenous
dose: 135 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
1262 ng × h/mL
2 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 2 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
2765 ng × h/mL
4 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 4 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
3429 ng × h/mL
6 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 6 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
4972 ng × h/mL
9 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 9 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
5078 ng × h/mL
14 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 14 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
6514 ng × h/mL
21 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 21 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
11508 ng × h/mL
32 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 32 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
29408 ng × h/mL
48 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 48 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
42140 ng × h/mL
72 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 72 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
80700 ng × h/mL
108 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 108 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
84899 ng × h/mL
135 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 135 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
47.7 h
2 mg/m² single, intravenous
dose: 2 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
61.5 h
4 mg/m² single, intravenous
dose: 4 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
57.9 h
6 mg/m² single, intravenous
dose: 6 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
58.9 h
9 mg/m² single, intravenous
dose: 9 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
48.2 h
14 mg/m² single, intravenous
dose: 14 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
46.4 h
21 mg/m² single, intravenous
dose: 21 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
60.3 h
32 mg/m² single, intravenous
dose: 32 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
48.9 h
48 mg/m² single, intravenous
dose: 48 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
43.8 h
72 mg/m² single, intravenous
dose: 72 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
47.4 h
108 mg/m² single, intravenous
dose: 108 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
50.8 h
135 mg/m² single, intravenous
dose: 135 mg/m²
route of administration: Intravenous
experiment type: SINGLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
43.1 h
2 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 2 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
52.6 h
4 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 4 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
57.8 h
6 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 6 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
51.1 h
9 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 9 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
51.9 h
14 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 14 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
57.3 h
21 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 21 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
53.2 h
32 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 32 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
39.8 h
48 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 48 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
42 h
72 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 72 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
43.7 h
108 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 108 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
40.2 h
135 mg/m² 1 times / 3 weeks multiple, intravenous
dose: 135 mg/m²
route of administration: Intravenous
experiment type: MULTIPLE
co-administered:
EMD-534085 plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
PubMed

PubMed

TitleDatePubMed
Cell type variation in responses to antimitotic drugs that target microtubules and kinesin-5.
2008-05-01
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 23:18:05 GMT 2025
Edited
by admin
on Mon Mar 31 23:18:05 GMT 2025
Record UNII
AL67QX8036
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
EMD-534085
Common Name English
(-)-EMD-534085
Preferred Name English
UREA, N-(2-(DIMETHYLAMINO)ETHYL)-N'-(((2R,4AS,5R,10BS)-3,4,4A,5,6,10B-HEXAHYDRO-5-PHENYL-9-(TRIFLUOROMETHYL)-2H-PYRANO(3,2-C)QUINOLIN-2-YL)METHYL)-
Systematic Name English
1-(2-(DIMETHYLAMINO)ETHYL)-3-(((2R,4AS,5R,10BS)-5-PHENYL-9-(TRIFLUOROMETHYL)-3,4,4A,5,6,10B-HEXAHYDRO-2H-PYRANO(3,2-C)QUINOLIN-2-YL)METHYL)UREA
Systematic Name English
Code System Code Type Description
SMS_ID
300000042440
Created by admin on Mon Mar 31 23:18:05 GMT 2025 , Edited by admin on Mon Mar 31 23:18:05 GMT 2025
PRIMARY
CAS
858668-07-2
Created by admin on Mon Mar 31 23:18:05 GMT 2025 , Edited by admin on Mon Mar 31 23:18:05 GMT 2025
PRIMARY
EPA CompTox
DTXSID90235147
Created by admin on Mon Mar 31 23:18:05 GMT 2025 , Edited by admin on Mon Mar 31 23:18:05 GMT 2025
PRIMARY
PUBCHEM
23634407
Created by admin on Mon Mar 31 23:18:05 GMT 2025 , Edited by admin on Mon Mar 31 23:18:05 GMT 2025
PRIMARY
CAS
1035647-06-3
Created by admin on Mon Mar 31 23:18:05 GMT 2025 , Edited by admin on Mon Mar 31 23:18:05 GMT 2025
SUPERSEDED
FDA UNII
AL67QX8036
Created by admin on Mon Mar 31 23:18:05 GMT 2025 , Edited by admin on Mon Mar 31 23:18:05 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY